The increasing incidence of HAI is increasing the demand for another healthcare setting to tackle the threat of HAIs. Home healthcare offers an alternative to hospitals owing to its convenience of treatment and the lesser threat of HAIs. Moreover, the increasing prevalence of chronic conditions, such as heart disease, cancer, and diabetes, that require regular patient monitoring are significantly contributing to the market growth. For instance, according to the American Cancer Society, 1,918,030 new cancer cases and 609,360 new cancer deaths were estimated in the U.S. in 2022. Such a high prevalence of cancer is expected to increase the demand for regular monitoring from home care settings and drive market growth.
Similarly, the increasing focus of market players on developing innovative solutions to meet the demand of patients in home care settings is further contributing to the market growth. For instance, in June 2022, Belluscura PLC announced the launch of X-PLOR, a Bluetooth-enabled oxygen concentrator with the Nomad Health app that allows patients to track their breathing rates, oxygen usage, heart rate, blood oxygen saturation levels, and other parameters. Developing such innovative solutions is easing the country's use of home durable medical equipment (DME), thereby driving market growth.
U.S. Home Durable Medical Equipment Market Report Highlights
- The increasing demand for home care settings in the country, owing to the convenience of treatment, the growing accessibility of innovative and easy-to-use home durable equipment, and the increasing geriatric population, is driving the market growth
- In July 2021, Advanced Diabetes Supply acquired US Medical Supply (US MED) from H.I.G. Capital. US MED is one of the major distributors of Continuous Glucose Monitors (CGM) and medical supplies in the U.S. This acquisition aimed to increase the company’s offering and quality of patient care
Table of Contents
Companies Mentioned
- Compass Health Brands
- Invacare Corporation
- Rotech Healthcare Inc.
- Medline Industries, LP
- Masimo
- ResMed
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 65 |
Published | May 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 13.33 Billion |
Forecasted Market Value ( USD | $ 20.39 Billion |
Compound Annual Growth Rate | 6.2% |
Regions Covered | United States |
No. of Companies Mentioned | 6 |